Chinese Journal of Antituberculosis ›› 2019, Vol. 41 ›› Issue (8): 848-856.doi: 10.3969/j.issn.1000-6621.2019.08.009
• Original Articles • Previous Articles Next Articles
Kun LI,Tai-jun LUO,Fei WANG,Hong-yan JIA,Zong-de ZHANG(),Wei LIU()
Received:
2019-04-29
Online:
2019-08-10
Published:
2019-08-13
Contact:
Zong-de ZHANG,Wei LIU
E-mail:zzd417@163.com;lw1200@sina.com
Kun LI,Tai-jun LUO,Fei WANG,Hong-yan JIA,Zong-de ZHANG,Wei LIU. Risk factors of acute kidney injury after surgery in adult spinal tuberculosis[J]. Chinese Journal of Antituberculosis, 2019, 41(8): 848-856. doi: 10.3969/j.issn.1000-6621.2019.08.009
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2019.08.009
临床观察指标 | 并发AKI组(31例) | 对照组(62例) | 统计值 | P值 |
---|---|---|---|---|
Scr(μmol/L, | 62.21±13.17 | 56.13±11.61 | t=2.274 | 0.025 |
eGFR [ml·min-1·(1.73m2)-1, | 97.12±13.18 | 105.42±19.36 | t=-3.355 | 0.001 |
BUN(mmol/L, | 4.37±1.46 | 4.54±1.89 | t=0.724 | 0.250 |
白蛋白(g/L, | 34.77±4.18 | 34.80±5.25 | t=-0.627 | 0.864 |
CRP[mg/L,M(Q1,Q3)] | 15.4(6.4,30.3) | 22.8(12.7,51.3) | U=699.000 | 0.175 |
抗结核药物治疗时间[d,M(Q1,Q3)] | 21.0(0.0,60.0) | 20.5(0.0,60.0) | U=948.500 | 0.917 |
手术时间(min, | 164.83±52.33 | 172.48±60.02 | t=-0.602 | 0.548 |
胶体量[ml,M(Q1,Q3)] | 1000.0(1000.0,1000.0) | 1000.0(1000.0,1000.0) | U=855.500 | 0.292 |
补液量[ml,M(Q1,Q3)] | 2900.0(2000.0,3500.0) | 2800.0(2375.0,3300.0) | U=935.500 | 0.834 |
失血量[ml,M(Q1,Q3)] | 600.0(500.0,1000.0) | 500.0(387.5,600.0) | U=628.000 | 0.006 |
输血量[ml,M(Q1,Q3)] | 600.0(0.0,800.0) | 200.0(0.0,400.0) | U=652.500 | 0.007 |
尿量 [ml,M(Q1,Q3)] | 200.0(200.0,320.0) | 200.0(137.0,362.0) | U=926.500 | 0.776 |
术后住院时间[d,M(Q1,Q3)] | 14.0(10.0,16.0) | 14.0(13.0,17.0) | U=844.000 | 0.334 |
补液量[ml,M(Q1,Q3)] | 2900.0(2000.0,3500.0) | 2800.0(2375.0,3300.0) | U=935.500 | 0.834 |
临床观察指标(变量) | 并发AKI组(31例) | 对照组(62例) | χ2值 | P值 | |||
---|---|---|---|---|---|---|---|
年龄(岁) | 4.216 | 0.040 | |||||
<60 | 11(35.48) | 36(58.06) | |||||
≥60 | 20(64.52) | 26(41.94) | |||||
性别 | 0.195 | 0.658 | |||||
男 | 15(48.39) | 27(43.55) | |||||
女 | 16(51.61) | 35(56.45) | |||||
BMI | 6.486 | 0.011 | |||||
<18 | 0(0.00) | 0(0.00) | |||||
18~ | 13(41.94) | 43(69.35) | |||||
>25 | 18(58.06) | 19(30.65) | |||||
既往史a | |||||||
高血压 | 17(54.84) | 18(29.03) | 5.864 | 0.015 | |||
糖尿病 | 7(22.58) | 6(9.68) | 1.889 | 0.169 | |||
心脏病 | 8(25.81) | 13(20.97) | 0.277 | 0.796 | |||
吸烟史 | 10(32.26) | 27(43.55) | 1.100 | 0.294 | |||
COPD | 3(9.68) | 5(8.06) | 0.001 | 1.000 | |||
抗结核药物治疗时间(d) | 0.087 | 0.769 | |||||
<21 | 16(51.61) | 34(54.84) | |||||
≥21 | 15(48.39) | 28(45.16) | |||||
临床观察指标(变量) | 并发AKI组(31例) | 对照组(62例) | χ2值 | P值 | |||
Scr(μmol/L) | 0.087 | 0.769 | |||||
<56 | 15(48.39) | 28(45.16) | |||||
≥56 | 16(51.61) | 34(54.84) | |||||
eGFR[ml·min-1·(1.73m2)-1] | 4.960 | 0.026 | |||||
<90 | 10(32.26) | 8(12.90) | |||||
≥90 | 21(67.74) | 54(87.10) | |||||
BUN(mmol) | 0.351 | 0.551 | |||||
<4.5 | 19(61.29) | 34(54.84) | |||||
≥4.5 | 12(38.71) | 28(45.16) | |||||
白蛋白(g/L) | 0.087 | 0.768 | |||||
≤35 | 13(41.94) | 28(45.16) | |||||
>35 | 18(58.06) | 34(54.84) | |||||
CRP(mg/L) | 2.225 | 0.136 | |||||
<15 | 16(51.61) | 22(35.48) | |||||
≥15 | 15(48.39) | 40(64.52) | |||||
高尿酸血症 | 4.043 | 0.044 | |||||
有 | 27(87.10) | 42(67.74) | |||||
无 | 4(12.90) | 20(32.26) | |||||
贫血 | 12.126 | 0.001 | |||||
有 | 17(54.84) | 12(19.35) | |||||
无 | 14(45.16) | 50(80.65) |
临床观察指标(变量) | 并发AKI组(31例) | 对照组(62例) | χ2值 | P值 | |
---|---|---|---|---|---|
ASA分级 | 1.902 | 0.168 | |||
Ⅱ | 17(54.84) | 43(69.35) | |||
Ⅲ | 14(45.16) | 19(30.65) | |||
麻醉方式 | 0.605 | 0.437 | |||
静脉滴注 | 19(61.29) | 43(69.35) | |||
静脉滴注+吸入 | 12(38.71) | 19(30.65) | |||
高血压a | 15(48.39) | 18(29.03) | 3.384 | 0.066 | |
低血压a | 21(67.74) | 38(61.29) | 0.373 | 0.543 | |
临床观察指标(变量) | 并发AKI组(31例) | 对照组(62例) | χ2值 | P值 | |
术中用药b | |||||
糖皮质激素 | 11(35.48) | 28(45.16) | 0.795 | 0.373 | |
乌司他丁 | 8(25.81) | 21(33.87) | 0.626 | 0.429 | |
磷酸肌酸 | 10(32.26) | 14(22.58) | 1.011 | 0.315 | |
氨甲环酸 | 10(32.26) | 31(50.00) | 2.639 | 0.104 | |
非甾体类抗炎药 | 8(25.81) | 22(35.48) | 0.886 | 0.347 | |
右美托咪定 | 13(41.94) | 40(64.52) | 4.299 | 0.038 | |
手术时间(min) | 0.086 | 0.769 | |||
<160 | 17(54.84) | 32(51.61) | |||
≥160 | 14(45.16) | 30(48.39) | |||
胶体量(ml) | 3.219 | 0.073 | |||
<1000 | 29(93.55) | 49(79.03) | |||
≥1000 | 2(6.45) | 13(20.97) | |||
补液量(ml) | 0.086 | 0.769 | |||
<2900 | 14(45.16) | 30(48.39) | |||
≥2900 | 17(54.84) | 32(51.61) | |||
失血量(ml) | 7.034 | 0.008 | |||
<600 | 11(35.48) | 40(64.52) | |||
≥600 | 20(64.52) | 22(35.48) | |||
输血量(ml) | 3.635 | 0.057 | |||
<400 | 11(35.48) | 35(56.45) | |||
≥400 | 20(64.52) | 27(43.55) | |||
尿量(ml) | 0.022 | 0.883 | |||
<200 | 17(54.84) | 35(56.45) | |||
≥200 | 14(45.16) | 27(43.55) | |||
术后肺部感染 | 0.079 | 0.779 | |||
有 | 8(25.80) | 12(19.35) | |||
无 | 23(74.20) | 50(80.65) | |||
术后住院时间(d) | 0.092 | 0.762 | |||
<14 | 11(35.48) | 24(38.71) | |||
≥14 | 20(64.52) | 38(61.29) | |||
治疗转归 | 0.486 | 0.215 | |||
死亡 | 1(3.23) | 0(0.00) | |||
存活 | 30(96.77) | 62(100.00) |
变量 | 赋值 | 变量 | 赋值 |
---|---|---|---|
X1年龄(岁) | 1=≥60;2=<60 | X17麻醉方式 | 1=静脉滴注;2=静脉滴注+吸入 |
X2性别 | 1=男;2=女 | X18低血压 | 1=有;2=无 |
X3 BMI | 1=>25;2=18~25 | X19高血压 | 1=有;2=无 |
X4术前高血压 | 1=有;2=否 | X20激素用药 | 1=使用;2=未使用 |
X5术前糖尿病 | 1=有;2=否 | X21乌司他丁 | 1=使用;2=未使用 |
X6术前心脏病 | 1=有;2=否 | X22磷酸肌酸 | 1=使用;2=未使用 |
X7术前吸烟史 | 1=有;2=无 | X23氨甲环酸 | 1=使用;2=未使用 |
X8抗结核药物治疗时间(d) | 1=≥21;2=<21 | X24右美托咪定 | 1=使用;2=未使用 |
X9血肌酐(μmol/L) | 1=≥56;2=<56 | X25非甾体类抗炎药 | 1=使用;2=未使用 |
X10 eGFR[ml·min-1·(1.73m2)-1] | 1=<90;2=≥90 | X26失血量(ml) | 1=≥600;2=<600 |
X11高尿酸血症 | 1=有;2=否 | X27输血量(ml) | 1=≥400;2=<400 |
X12贫血 | 1=有;2=否 | X28尿量(ml) | 1=<200;2=≥200 |
X13尿素氮(mmol/L) | 1=≥4.5;2=<4.5 | X29术后肺部感染 | 1=有;2=无 |
X14白蛋白(g/L) | 1=≤35;2=>35 | X30术后住院天数(d) | 1=≥14;2=<14 |
X15 CRP(mg/L) | 1=>15;2=0~15 | X31死亡例数 | 1=有;2=无 |
X16 ASA分级 | 1=Ⅱ级;2=Ⅲ级 | Y急性肾损伤 | 1=发生;2=未发生 |
[1] | 兰汀隆, 秦世炳 . 严格掌握脊柱结核手术指征并选择合适的手术时机和方式. 中国防痨杂志, 2017,39(4):327-328. |
[2] | Thakar CV . Perioperative acute kidney injury. Adv Chronic Kidney Dis, 2013,20(1):67-75. |
[3] | American Society of Anesthesiologists. Practice Advisory for the Prevention, Diagnosis, and Management of Infectious Complications Associated with Neuraxial Techniques: An Updated Report by the American Society of Anesthesiologists Task Force on Infectious Complications Associat. Anesthesio-logy, 2017,126(4):585-601. |
[4] | National Collaborating Centre for Chronic Conditions (UK), Centre for Clinical Practice at NICE (UK). Tuberculosis: Clinical diagnosis and management of tuberculosis, and mea-sures for its prevention and control. London:National Institute for Health and Clinical Excellence(UK), 2011. |
[5] | Khwaja A . KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract, 2012,120(4):c179-184. |
[6] | 张勇, 郭惠明, 叶智明 . 心脏外科手术后并发急性肾损伤276例回顾性分析. 岭南心血管病杂志, 2013,19(2):137-141. |
[7] | Levey AS, Stevens LA, Schmid CH , et al. A new equation to estimate glomerular filtration rate. Ann Intern Med, 2009,150(9):604-612. |
[8] | 中国医师协会肾脏内科医师分会. 中国肾脏疾病高尿酸血症诊治的实践指南(2017版). 中华医学杂志, 2017,97(25):1927-1936. |
[9] | DeLoughery TG . Iron Deficiency Anemia. The Med Clini North Am, 2017,101(2):319-332. |
[10] | Grams ME, Sang Y, Coresh J , et al. Acute Kidney Injury after Major Surgery: A Retrospective Analysis of Veterans Health Administration Data. Am J Kidney Dis, 2016,67(6):872-880. |
[11] | Uchino S, Bellomo R, Bagshaw SM , et al. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrolo Dial Transplant, 2010,25(6):1833-1839. |
[12] | Greenberg JH, Coca S, Parikh CR . Long-term risk of chronic kidney disease and mortality in children after acute kidney injury: a systematic review. BMC Nephrol, 2014,15:184. |
[13] | Li S, Wang S, Priyanka P , et al. Acute Kidney Injury in Critically Ⅲ Patients After Noncardiac Major Surgery: Early Versus Late Onset. Crit Care Med, 2019,47(6):e437-444. |
[14] | Ponte B, Felipe C, Muriel A , et al. Long-term functional evolution after an acute kidney injury: a 10-year study. Nephrolo Dial Transplant, 2008,23(12):3859-3866. |
[15] | Coca SG, Yusuf B, Shlipak MG , et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis, 2009,53(6):961-973. |
[16] | Naik BI, Colquhoun DA, McKinney WE , et al. Incidence and risk factors for acute kidney injury after spine surgery using the RIFLE classification. J Neurosurg Spine, 2014,20(5):505-511. |
[17] | Chaudery H, MacDonald N, Ahmad T , et al. Acute Kidney Injury and Risk of Death After Elective Surgery: Prospective Analysis of Data From an International Cohort Study. Anesth Analg, 2019,128(5):1022-1029. |
[18] | Haanschoten MC, van Straten AH, Bouwman A , et al. Impact of postoperative renal replacement therapy on long-term outcome after cardiac surgery increases with age. J Card Surg, 2014,29(4):464-469. |
[19] | Ejaz AA, Dass B, Lingegowda V , et al. Effect of uric acid lowering therapy on the prevention of acute kidney injury in cardiovascular surgery. Int Urol Nephrol, 2013,45(2):449-458. |
[20] | Cho W, Hwang TY, Choi YK , et al. Diastolic dysfunction and acute kidney injury in elderly patients with femoral neck fracture. Kidney Res Clin Pract, 2019,38(1):33-41. |
[21] | Kang DH, Park SK, Lee IK , et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol, 2005,16(12):3553-3562. |
[22] | Shimada M, Dass B, Ejaz AA . Paradigm shift in the role of uric acid in acute kidney injury. Semin Nephrol, 2011,31(5):453-458. |
[23] | Kaufeld T, Foerster KA , Schilling,et al.Preoperative serum uric acid predicts incident acute kidney injury following cardiac surgery. BMC Nephrol, 2018,19(1):161. |
[24] | Candela-Toha Á, Pardo MC, Pérez T , et al. Estimated glomeru-lar filtration rate is an early biomarker of cardiac surgery-associated acute kidney injury. Nefrologia, 2018,38(6):596-605. |
[25] | Hsu CY, Ordoñez JD, Chertow GM , et al. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int, 2008,74(1):101-107. |
[26] | Nagu TJ, Spiegelman D, Hertzmark E , et al. Anemia at the initiation of tuberculosis therapy is associated with delayed sputum conversion among pulmonary tuberculosis patients in Dar-es-Salaam, Tanzania. PLoS One, 2014,9(3):e91229. |
[27] | Gil-Santana L, Cruz LAB, Arriaga MB , et al. Tuberculosis-associated anemia is linked to a distinct inflammatory profile that persists after initiation of antitubercular therapy. Sci Rep, 2019,9(1):1381. |
[28] | Karkouti K, Wijeysundera DN, Yau TM , et al. Influence of erythrocyte transfusion on the risk of acute kidney injury after cardiac surgery differs in anemic and nonanemic patients. Anesthesiology, 2011,115(3):523-530. |
[29] | Iyigun M, Aykut G, Tosun M , et al. Perioperative risk factors of acute kidney injury after non-cardiac surgery: A multicenter,prospective, observational study in patients with low grade American Society of Anesthesiologists physical status. Am J Surg, 2019.pii: S0002-9610(18)31643-X. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||